BGNE BeiGene Ltd

Price (delayed)

$182.01

Market cap

$19.05B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.71

Enterprise value

$16.55B

Highlights

The company's gross profit has surged by 88% YoY and by 25% QoQ

The revenue has soared by 76% YoY and by 22% from the previous quarter

BeiGene's quick ratio has decreased by 27% YoY

The equity has contracted by 19% YoY

Sector: Healthcare

Industry: Biotechnology

Website: http://www.beigene.com/

Peers: OGN

Key stats

What are the main financial stats of BGNE

Market

Shares outstanding

104.68M

Market cap

$19.05B

Enterprise value

$16.55B

Valuations

Price to earnings (P/E)

N/A

Price to book (P/B)

5.13

Price to sales (P/S)

8.65

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

7.51

Earnings

Revenue

$2.2B

EBIT

-$981.98M

EBITDA

-$900.11M

Free cash flow

-$1.79B

Per share

EPS

-$0.71

Free cash flow per share

-$17.08

Book value per share

$35.51

Revenue per share

$21.04

TBVPS

$52.22

Balance sheet

Total assets

$5.52B

Total liabilities

$1.76B

Debt

$579.77M

Equity

$3.76B

Working capital

$2.77B

Liquidity

Debt to equity

0.15

Current ratio

3.16

Quick ratio

2.72

Net debt/EBITDA

2.78

Margins

EBITDA margin

-40.8%

Gross margin

84.2%

Net margin

-43.5%

Operating margin

-58.6%

Efficiency

Return on assets

-16.3%

Return on equity

-23.8%

Return on invested capital

-60.5%

Return on capital employed

-23.2%

Return on sales

-44.5%

Dividend

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

BGNE stock price

How has the BeiGene stock price performed over time

Intraday

-1.16%

1 week

-0.61%

1 month

-7.2%

1 year

-2.97%

YTD

-17.25%

QTD

1.19%

Financial performance

How have BeiGene's revenue and profit performed over time

Revenue

$2.2B

Gross profit

$1.86B

Operating income

-$1.29B

Net income

-$959.49M

Gross margin

84.2%

Net margin

-43.5%

The company's gross profit has surged by 88% YoY and by 25% QoQ

The revenue has soared by 76% YoY and by 22% from the previous quarter

BeiGene's net margin has soared by 75% YoY and by 55% from the previous quarter

BGNE's operating margin has surged by 61% year-on-year and by 34% since the previous quarter

Growth

What is BeiGene's growth rate over time

Valuation

What is BeiGene stock price valuation

P/E

N/A

P/B

5.13

P/S

8.65

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

7.51

The company's EPS has surged by 57% YoY and by 45% QoQ

The equity has contracted by 19% YoY

The price to book (P/B) is 9% lower than the 5-year quarterly average of 5.7

The revenue has soared by 76% YoY and by 22% from the previous quarter

BGNE's price to sales (P/S) is 71% lower than its 5-year quarterly average of 30.2 and 29% lower than its last 4 quarters average of 12.3

Efficiency

How efficient is BeiGene business performance

The company's return on sales has surged by 74% YoY and by 54% QoQ

BeiGene's ROIC has increased by 43% from the previous quarter and by 30% YoY

The company's return on assets rose by 42% QoQ and by 42% YoY

BGNE's return on equity is up by 42% since the previous quarter and by 39% year-on-year

Dividends

What is BGNE's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for BGNE.

Financial health

How did BeiGene financials performed over time

BeiGene's quick ratio has decreased by 27% YoY

The current ratio is down by 22% year-on-year

BeiGene's debt is 85% less than its equity

The equity has contracted by 19% YoY

BeiGene's debt has decreased by 18% YoY and by 14% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.